ViewRay, Inc. Overview
Pro stress-test →ViewRay designs, manufactures and markets MRIdian, an MR Image-Guided radiation therapy system to simultaneously image and treat cancer patients. The product is used for the treatment of pancreas, prostate, lung, liver, breast, and oligometastatic cancers. The company represents innovative precision oncology technology with significant clinical applications.
Strategic Profile
Pro stress-test →MRIdian's high-definition MR was purpose-built to address specific challenges, including beam distortion, skin toxicity, and other concerns that may arise when high magnetic fields interact with radiation beams. However, the company faces critical operational challenges following recent bankruptcy proceedings, impacting its competitive positioning and market availability.
Competitive Landscape
Pro stress-test →Competitors include NorthStar Medical Radioisotopes, Bomimed, Best Theratronics, Accuray, and CivaTech Oncology. ViewRay's position in this landscape is severely compromised by its bankruptcy liquidation status, limiting competitive engagement.
Industry Context
ViewRay, Inc. operates in Medical Devices - Radiation Oncology.
Key facts
Founded: 2004 · Headquarters: Oakwood, Ohio · Employees: N/A · Revenue: $100M (TTM as of 2023) · Market cap: N/A